These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24009543)

  • 41. Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus.
    Fan H; Tong T; Chen H; Guo A
    Virus Genes; 2007 Oct; 35(2):347-57. PubMed ID: 17497212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New generation of mucosal adjuvants for the induction of protective immunity.
    Yuki Y; Kiyono H
    Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of the Foot-and-Mouth Disease Virus VP1 protein using a replication-competent recombinant canine adenovirus type 2 elicits a humoral antibody response in a porcine model.
    Liu Y; Hu R; Zhang S; Zhang F; Li Z; Wei X; Chen L
    Viral Immunol; 2006; 19(2):202-9. PubMed ID: 16817763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Roles of M cells in infection and mucosal vaccines.
    Wang M; Gao Z; Zhang Z; Pan L; Zhang Y
    Hum Vaccin Immunother; 2014; 10(12):3544-51. PubMed ID: 25483705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a recombinant vaccine against foot and mouth disease utilizing mutant attenuated Listeria ivanovii strain as a live vector.
    Mahdy SE; Sijing L; Lin S; Xiang Z; Hao-Tai C; Xiaofang P; Chuan W
    J Virol Methods; 2019 Nov; 273():113722. PubMed ID: 31422118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine.
    Periwal SB; Kourie KR; Ramachandaran N; Blakeney SJ; DeBruin S; Zhu D; Zamb TJ; Smith L; Udem S; Eldridge JH; Shroff KE; Reilly PA
    Vaccine; 2003 Jan; 21(5-6):376-85. PubMed ID: 12531635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenicity of a neutralizing epitope from porcine epidemic diarrhea virus: M cell targeting ligand fusion protein expressed in transgenic rice calli.
    Huy NX; Kim SH; Yang MS; Kim TG
    Plant Cell Rep; 2012 Oct; 31(10):1933-42. PubMed ID: 22736145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral Immunization with a Recombinant Lactococcus lactis-Expressing HIV-1 Antigen on Group A Streptococcus Pilus Induces Strong Mucosal Immunity in the Gut.
    Chamcha V; Jones A; Quigley BR; Scott JR; Amara RR
    J Immunol; 2015 Nov; 195(10):5025-34. PubMed ID: 26482408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Foot-and-Mouth Disease Virus Capsid Protein VP1 Interacts with Host Ribosomal Protein SA To Maintain Activation of the MAPK Signal Pathway and Promote Virus Replication.
    Zhu Z; Li W; Zhang X; Wang C; Gao L; Yang F; Cao W; Li K; Tian H; Liu X; Zhang K; Zheng H
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice.
    Song X; Bao S; Wu L; Hu S
    Vaccine; 2009 Jan; 27(1):51-5. PubMed ID: 18973783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Foot-and-mouth disease virus VP1 target the MAVS to inhibit type-I interferon signaling and VP1 E83K mutation results in virus attenuation.
    Ekanayaka P; Lee SY; Herath TUB; Kim JH; Kim TH; Lee H; Chathuranga K; Chathuranga WAG; Park JH; Lee JS
    PLoS Pathog; 2020 Nov; 16(11):e1009057. PubMed ID: 33232374
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune responses to the oral administration of recombinant Bacillus subtilis expressing multi-epitopes of foot-and-mouth disease virus and a cholera toxin B subunit.
    Hu B; Li C; Lu H; Zhu Z; Du S; Ye M; Tan L; Ren D; Han J; Kan S; Wang J; Jin N
    J Virol Methods; 2011 Jan; 171(1):272-9. PubMed ID: 21129406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune Responses.
    Pais R; Omosun Y; Igietseme JU; Fujihashi K; Eko FO
    Front Immunol; 2019; 10():1577. PubMed ID: 31333682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses.
    Lo DD; Ling J; Eckelhoefer AH
    BMC Biotechnol; 2012 Mar; 12():7. PubMed ID: 22413871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IgA antibody response of swine to foot-and-mouth disease virus infection and vaccination.
    Pacheco JM; Butler JE; Jew J; Ferman GS; Zhu J; Golde WT
    Clin Vaccine Immunol; 2010 Apr; 17(4):550-8. PubMed ID: 20107003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incorporation of a bi-functional protein FimH enhances the immunoprotection of chitosan-pVP1 vaccine against coxsackievirus B3-induced myocarditis.
    Fan X; Yue Y; Xiong S
    Antiviral Res; 2017 Apr; 140():121-132. PubMed ID: 28137624
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of immune responses against FMD by a DNA vaccine encoding the FMDV/O/IRN/2007 VP1 gene and the conventional inactivated vaccine in an animal model.
    Sedeh FM; Soleimanjahi H; Jalilian A; Mahravani H
    Virol Sin; 2012 Oct; 27(5):286-91. PubMed ID: 23001482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of cytotoxic T lymphocyte function after foot-and-mouth disease virus infection and vaccination.
    Patch JR; Kenney M; Pacheco JM; Grubman MJ; Golde WT
    Viral Immunol; 2013 Aug; 26(4):239-49. PubMed ID: 23829779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Local and systemic immune responses induced by intranasal immunization with biomineralized foot-and-mouth disease virus-like particles.
    Li S; Zhao R; Song H; Pan S; Zhang Y; Dong H; Bai M; Sun S; Guo H; Yin S
    Front Microbiol; 2023; 14():1112641. PubMed ID: 36819011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral Delivery of Probiotics Expressing Dendritic Cell-Targeting Peptide Fused with Porcine Epidemic Diarrhea Virus COE Antigen: A Promising Vaccine Strategy against PEDV.
    Wang X; Wang L; Huang X; Ma S; Yu M; Shi W; Qiao X; Tang L; Xu Y; Li Y
    Viruses; 2017 Oct; 9(11):. PubMed ID: 29068402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.